Research167d agoScotiabank Downgrades TELUS to Sector Perform From Sector Outperform, Adjusts Price Target to CA$21.50 From CA$23$TU
Research167d agoCitigroup Downgrades Similarweb to Neutral From Buy, Adjusts PT to $3 From $8.50Similarweb (SMWB) has an average rating of overweight and mean price target of $5.42, according to analysts polled by FactSet.$SMWB
Research167d agoJPMorgan Downgrades Nutanix to Neutral From Overweight, Adjusts PT to $44 From $55Nutanix (NTNX) has an average rating of overweight and mean price target of $55.71, according to analysts polled by FactSet.$NTNX
Research167d agoCitigroup Downgrades Veeva Systems to Neutral From Buy, Adjusts Price Target to $176 From $291Veeva Systems (VEEV) has an average rating of overweight and mean price target of $272.19, according to analysts polled by FactSet.$VEEV
Research167d agoCitigroup Downgrades DocuSign to Neutral From Buy, Adjusts PT to $50 From $99DocuSign (DOCU) has an average rating of Hold and mean price target of $62.33, according to analysts polled by FactSet.$DOCU
Research167d agoStephens Downgrades Simply Good Foods to Equalweight From Overweight, Adjusts Price Target to $14 From $24Simply Good Foods (SMPL) has an average rating of overweight and mean price target of $19.50, according to analysts polled by FactSet.$SMPL
Research167d agoCitigroup Downgrades NICE to Neutral From Buy, Adjusts Price Target to $119 From $184$NICE
Research167d agoCitigroup Downgrades CCC Intelligent Solutions to Neutral From Buy, Cuts Price Target to $6 From $10CCC Intelligent Solutions (CCC) has an average rating of overweight and mean price target of $9.33, according to analysts polled by FactSet.$CCC
Research167d agoWells Fargo Downgrades Axalta Coating Systems to Equal Weight From Overweight, Adjusts Price Target to $30 From $39Axalta Coating Systems (AXTA) has an average rating of overweight and mean price target of $36.64, according to analysts polled by FactSet.$AXTA
Research167d agoB. Riley Upgrades MacroGenics to Buy From Neutral, Triples Price Target to $9 From $3MacroGenics (MGNX) has an average rating of hold and mean price target of $4, according to analysts polled by FactSet.$MGNX
Research167d agoMorgan Stanley Upgrades Ryman Hospitality Properties to Overweight From Equalweight, Price Target is $88Ryman Hospitality Properties (RHP) has an average rating of buy and mean price target of $115.20, according to analysts polled by FactSet.$RHP
Research167d agoBTIG Initiates WhiteFiber at Buy With $20 Price TargetWhiteFiber (WYFI) has an average rating of buy and mean price target of $28.64, according to analysts polled by FactSet.$WYFI
Research167d agoMizuho Upgrades Shake Shack to Outperform From Neutral, Adjusts Price Target to $120 From $100Shake Shack (SHAK) has an average rating of overweight and mean price target of $114.20, according to analysts polled by FactSet.$SHAK
Research167d agoCantor Fitzgerald Initiates Coverage on Mechanics Bancorp With Overweight Rating, $17 Price TargetMechanics Bancorp (MCHB) has an average rating of overweight and mean price target of $16.50, according to analysts polled by FactSet.$MCHB
Research167d agoRaymond James Initiates Milestone Pharmaceuticals at Strong BuyMilestone Pharmaceuticals (MIST) has an average rating of buy and mean price target of $6.50, according to analysts polled by FactSet.$MIST
Research167d agoCitigroup Upgrades Nexstar Media Group to Buy From Neutral, Adjusts Price Target to $220 From $252Nexstar Media Group (NXST) has an average rating of overweight and mean price target of $271.43, according to analysts polled by FactSet.$NXST
Research167d agoLoop Capital Initiates Coverage on MACOM Technology Solutions With Buy RatingMACOM Technology Solutions Holdings (MTSI) has an average rating of overweight and mean price target of $265.07, according to analysts polled by FactSet.$MTSI
Research167d agoNeedham & Co Initiates Coverage on Lyell Immunopharma With Strong Buy Rating, $44 Price TargetLyell Immunopharma (LYEL) has an average rating of Buy and mean price target of $40.50, according to analysts polled by FactSet.$LYEL
Research167d agoRaymond James Initiates United Therapeutics at OutperformUnited Therapeutics (UTHR) has an average rating of overweight and mean price target of $654.42, according to analysts polled by FactSet.$UTHR